<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03068156</url>
  </required_header>
  <id_info>
    <org_study_id>CU_308excimer_amyloidosis</org_study_id>
    <nct_id>NCT03068156</nct_id>
  </id_info>
  <brief_title>Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians</brief_title>
  <official_title>Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ratchadapiseksompotch Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in
      Asians, pilot study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Anticipated">March 2, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Roughness evaluation by using VisioscanÂ® VC98</measure>
    <time_frame>Change from baseline roughness at every 2 weeks up to 16 weeks</time_frame>
    <description>The improvement of roughness evaluation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Lichen Amyloidosis</condition>
  <arm_group>
    <arm_group_label>excimer laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>308-nm excimer laser</intervention_name>
    <description>monochromator UVB laser (308nm)</description>
    <arm_group_label>excimer laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients, aged &gt;18 years old with lichen amyloidosis diagnosed by using clinical
             presentation and pathologic features

        Exclusion Criteria:

          -  Those with cutaneous amyloidosis associated systemic diseases

          -  Pregnancy or lactating woman

          -  Those who are allergic to urea, olive oil

          -  Those who are photosensitive to ultraviolet radiation

          -  Those who had been previously treated with medications/ radiation/ laser within 3
             months for systemic and 1 month for topical therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Einapak Amnarttrakul, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Einapak Amnarttrakul, M.D.</last_name>
    <phone>7521182743</phone>
    <email>einapak.b@chula.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pravit Asawanonda, M.D., PhD</last_name>
    <phone>66818129393</phone>
    <email>pravit.a@chula.ac.th, fibrosis@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anukorn Sriaram, B.Eng.</last_name>
      <phone>66860645757</phone>
      <email>photochulateam@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jaruwan Pemcharoen, B.Sc.</last_name>
      <phone>66823573912</phone>
      <email>photochulateam@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Pawinee Rerknimitr, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chanat Kumtornrat, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kitipong Wantavornprasert, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2017</study_first_submitted>
  <study_first_submitted_qc>February 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2017</study_first_posted>
  <last_update_submitted>February 26, 2017</last_update_submitted>
  <last_update_submitted_qc>February 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>308-nm excimer laser</keyword>
  <keyword>primary localized cutaneous amyloidosis</keyword>
  <keyword>lichen amyloidosis</keyword>
  <keyword>Asians</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Skin Diseases, Genetic</mesh_term>
    <mesh_term>Amyloidosis, Familial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

